文献速递泌尿生殖MR

前列腺磁共振成像在根治性放疗后组织学确诊前列腺癌复发局部复发报告中的临床应用

The clinical application of prostate magnetic resonance imaging for local recurrence reporting in histologically confirmed prostate cancer recurrence after radical radiotherapy.
PubMed 文献 · Br J Radiol · 2026-01-01

单中心回顾性研究纳入145例放疗后前列腺癌复发患者,评估PI-RR评分对组织学确诊肿瘤的分类效能,并分析DWI/ADC及动态增强参数。87.6%患者PI-RR评分为4-5分,ADC值1.13×10⁻³ mm²/s鉴别良恶性病变的ROC AUC为0.859;PI-RR≤3分者中结合ADC与增强曲线可优化复发高风险病灶分类。

要点

  • 放疗后前列腺癌复发评估中,87.6%组织学确诊复发灶PI-RR评分为4-5分。
  • ADC值1.13×10⁻³ mm²/s鉴别良恶性病灶的ROC AUC为0.859。
  • PI-RR≤3分病灶中,ADC<1.13×10⁻³ mm²/s或流出/平台型增强曲线提示恶性可能。

核心结论

  • 多数患者(87.6%)PI-RR评分为4或5分,提示局部复发可能性高或非常高;PI-RR≤3分者中,ADC值与增强曲线类型可能有助于更好分类高复发风险病灶。

研究设计与样本

  • 单中心回顾性研究,纳入145例放疗后前列腺癌复发患者(年龄70.8±6.8岁),行多参数磁共振成像(mpMRI)及活检(2007-2021年),采用非参数检验和ROC曲线评估ADC参数的诊断价值。

关键影像表现/征象

  • PI-RR 4-5分者127例(87.6%),PI-RR 2-3分者18例(12%)。
  • PI-RR 2分和3分病灶分别见于2例和16例患者。
  • PI-RR 2-3分病灶中12例ADC<1.13×10⁻³ mm²/s,可考虑为恶性。
  • PI-RR 2-3分病灶中增强曲线流出型6/18、平台型6/18,仅6/18呈持续强化(可能良性)。
  • 结合ADC与增强曲线类型,仅2例病灶不符合恶性标准。

诊断标准与关键数值

  • 以组织学确诊为参考,ADC值1.13×10⁻³ mm²/s鉴别良恶性病灶的ROC AUC为0.859。
  • PI-RR评分4-5分定义为局部复发可能性高或非常高。
  • PI-RR 2-3分病灶中ADC<1.13×10⁻³ mm²/s可考虑为恶性。

临床应用与阅片要点

  • 报告放疗后前列腺癌复发时采用PI-RR评分,4-5分提示局部复发可能性高或非常高。
  • 对PI-RR≤3分病灶,结合ADC值(以1.13×10⁻³ mm²/s为界)和增强曲线类型(流出/平台型)辅助判断恶性风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine if histologically confirmed tumours were categorized as highly suspicious according to Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR). Moreover, additional diffusion-weighted images/apparent diffusion coefficient (DWI/ADC) and dynamic contrast-enhancement parameters were analysed for more precise diagnosis.

METHODS: A single-centre retrospective study on 145 patients (aged 70.8 ± 6.8) with prostate cancer recurrence after radiation therapy. Patients underwent multiparametric magnetic resonance imaging (mpMRI) and biopsy (2007-2021). We employed nonparametric tests and Receiver operating characteristic (ROC) curves to determine the diagnostic value of the ADC parameter.

RESULTS: Most patients 127 (87.6%) had a high and very high likelihood of local recurrence (PI-RR 4-5), while 18 (12%) had PI-RR 2-3. The ADC value of 1.13 × 10-3 mm2/s best differentiated between benign and malignant lesions (ROC AUC 0.859). PI-RR 2 and 3 scores were found in 2 and 16 patients, respectively. Of these lesions, 12 showed low ADC (<1.13 × 10-3 mm2/s), which could be considered malignant. As regards the enhancement curve, 6/18 had wash-out, 6/18 had plateau. Only 6/18 lesions had persistent curve enhancement (potentially benign). Considering ADC and enhancement curve type, only 2 lesions did not meet the criteria for malignancy.

CONCLUSIONS: Most patients (87.6%) had a high or very high likelihood of local recurrence (PI-RR score 4 or 5). In patients with PI-RR ≤3 scores, the ADC value and the enhancement type may allow for better classification of lesions with a high risk of recurrence.

ADVANCED IN KNOWLEDGE: Detailed mpMRI evaluation can estimate prostate cancer recurrence risk with very high accuracy using PI-RR score, the ADC value, and the enhancement curve type.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Rembak-Szynkiewicz J, Hebda A, Mazgaj P, et al. The clinical application of prostate magnetic resonance imaging for local recurrence reporting in histologically confirmed prostate cancer recurrence after radical radiotherapy. Br J Radiol. 2026. PMID: 41212262. doi:10.1093/bjr/tqaf273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。